tetano
Editor, Senior Moderator
BMC Med Genomics
. 2024 Jan 29;17(1):40.
doi: 10.1186/s12920-023-01793-4. Association of IL-10-592 C > A /-1082 A > G and the TNFα -308 G > A with susceptibility to COVID-19 and clinical outcomes
Raghda E Eldesouki[SUP] 1 [/SUP], Rania M Kishk[SUP] 2 [/SUP], Noha M Abd El-Fadeal[SUP] 3 4 [/SUP], Rama I Mahran[SUP] 5 [/SUP], Noha Kamel[SUP] 6 [/SUP], Eman Riad[SUP] 7 [/SUP], Nader Nemr[SUP] 8 [/SUP], Safaa M Kishk[SUP] 8 [/SUP], Eman Abdel-Moemen Mohammed[SUP] 9 [/SUP]
Affiliations
Background: Variation in host immune responses to SARS-CoV-2 is regulated by multiple genes involved in innate viral response and cytokine storm emergence like IL-10 and TNFa gene polymorphisms. We hypothesize that IL-10; -592 C > A and - 1082 A > G and TNFa-308 G > A are associated with the risk of SARS-COV2 infections and clinical outcome.
Methods: Genotyping, laboratory and radiological investigations were done to 110 COVID-19 patients and 110 healthy subjects, in Ismailia, Egypt.
Results: A significant association between the - 592 A allele, A containing genotypes under all models (p < 0.0001), and TNFa A allele with risk to infection was observed but not with the G allele of the - 1082. The - 592 /-1082 CG and the - 592 /-1082/ -308 CGG haplotypes showed higher odds in COVID-19 patients. Severe lung affection was negatively associated with - 592, while positive association was observed with - 1082. Higher D-dimer levels were strongly associated with the - 1082 GG genotype. Survival outcomes were strongly associated with the GA genotype of TNFa. -308 as well as AGG and AAA haplotypes.
Conclusion: IL-10 and TNFa polymorphisms should be considered for clinical and epidemiological evaluation of COVID-19 patients.
Keywords: COVID-19; Egypt; Genotype; IL-10; Innate immunity; Pharmacogenomics; Polymorphism; Remdesivir; SARS-CoV-2; SNP; TNFa; rs1800629(-308); rs1800872 (− 592); rs1800896(− 1082).
. 2024 Jan 29;17(1):40.
doi: 10.1186/s12920-023-01793-4. Association of IL-10-592 C > A /-1082 A > G and the TNFα -308 G > A with susceptibility to COVID-19 and clinical outcomes
Raghda E Eldesouki[SUP] 1 [/SUP], Rania M Kishk[SUP] 2 [/SUP], Noha M Abd El-Fadeal[SUP] 3 4 [/SUP], Rama I Mahran[SUP] 5 [/SUP], Noha Kamel[SUP] 6 [/SUP], Eman Riad[SUP] 7 [/SUP], Nader Nemr[SUP] 8 [/SUP], Safaa M Kishk[SUP] 8 [/SUP], Eman Abdel-Moemen Mohammed[SUP] 9 [/SUP]
Affiliations
- PMID: 38287362
- PMCID: PMC10826193
- DOI: 10.1186/s12920-023-01793-4
Background: Variation in host immune responses to SARS-CoV-2 is regulated by multiple genes involved in innate viral response and cytokine storm emergence like IL-10 and TNFa gene polymorphisms. We hypothesize that IL-10; -592 C > A and - 1082 A > G and TNFa-308 G > A are associated with the risk of SARS-COV2 infections and clinical outcome.
Methods: Genotyping, laboratory and radiological investigations were done to 110 COVID-19 patients and 110 healthy subjects, in Ismailia, Egypt.
Results: A significant association between the - 592 A allele, A containing genotypes under all models (p < 0.0001), and TNFa A allele with risk to infection was observed but not with the G allele of the - 1082. The - 592 /-1082 CG and the - 592 /-1082/ -308 CGG haplotypes showed higher odds in COVID-19 patients. Severe lung affection was negatively associated with - 592, while positive association was observed with - 1082. Higher D-dimer levels were strongly associated with the - 1082 GG genotype. Survival outcomes were strongly associated with the GA genotype of TNFa. -308 as well as AGG and AAA haplotypes.
Conclusion: IL-10 and TNFa polymorphisms should be considered for clinical and epidemiological evaluation of COVID-19 patients.
Keywords: COVID-19; Egypt; Genotype; IL-10; Innate immunity; Pharmacogenomics; Polymorphism; Remdesivir; SARS-CoV-2; SNP; TNFa; rs1800629(-308); rs1800872 (− 592); rs1800896(− 1082).